Neuroscientist's work leads to clinical trial for early Alzheimer's treatment
December 23, 2024
December 23, 2024
ITHACA, New York, Dec. 23 -- Cornell University issued the following news:
Neuroscientist Gary Gibson, Ph.D. '73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer's disease on his office wall.
The image is a memento of Gibson's breakthrough hypothesis about an underlying cause of mild cognitive impairment and Alzheimer's that an insufficiency of vitamin B1 called thiamine alters the ability of mitochondria in br . . .
Neuroscientist Gary Gibson, Ph.D. '73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer's disease on his office wall.
The image is a memento of Gibson's breakthrough hypothesis about an underlying cause of mild cognitive impairment and Alzheimer's that an insufficiency of vitamin B1 called thiamine alters the ability of mitochondria in br . . .